Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$81.24 - $97.37 $1.21 Million - $1.45 Million
-14,883 Reduced 16.36%
76,079 $6.29 Million
Q1 2024

May 15, 2024

BUY
$71.24 - $85.35 $1.5 Million - $1.79 Million
21,022 Added 30.06%
90,962 $7.76 Million
Q4 2023

Feb 14, 2024

SELL
$80.59 - $92.61 $1.53 Million - $1.76 Million
-19,022 Reduced 21.38%
69,940 $5.98 Million
Q3 2023

Nov 14, 2023

SELL
$82.56 - $93.49 $2.15 Million - $2.44 Million
-26,099 Reduced 22.68%
88,962 $7.97 Million
Q2 2023

Aug 11, 2023

SELL
$80.84 - $89.45 $2.08 Million - $2.3 Million
-25,679 Reduced 18.25%
115,061 $9.8 Million
Q1 2023

May 12, 2023

BUY
$72.75 - $90.6 $608,335 - $757,597
8,362 Added 6.32%
140,740 $11.6 Million
Q4 2022

Feb 13, 2023

BUY
$73.85 - $86.14 $1.22 Million - $1.43 Million
16,581 Added 14.32%
132,378 $10.4 Million
Q3 2022

Nov 14, 2022

BUY
$63.3 - $78.66 $5.75 Million - $7.14 Million
90,797 Added 363.19%
115,797 $8.57 Million
Q2 2022

Aug 12, 2022

BUY
$49.27 - $66.08 $1.23 Million - $1.65 Million
25,000 New
25,000 $1.63 Million
Q2 2021

Aug 13, 2021

SELL
$51.81 - $118.56 $906,675 - $2.07 Million
-17,500 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$111.01 - $139.48 $1.94 Million - $2.44 Million
17,500 New
17,500 $1.94 Million
Q3 2020

Nov 13, 2020

SELL
$75.65 - $93.58 $2.28 Million - $2.82 Million
-30,147 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$84.96 - $118.91 $1.27 Million - $1.78 Million
15,000 Added 99.03%
30,147 $2.7 Million
Q1 2020

May 15, 2020

SELL
$74.34 - $121.82 $3.35 Million - $5.49 Million
-45,103 Reduced 74.86%
15,147 $1.51 Million
Q4 2019

Feb 13, 2020

BUY
$114.37 - $129.46 $6.89 Million - $7.8 Million
60,250 New
60,250 $6.92 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.23B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.